AU4632085A - Novel radiopharmaceuticals and chelating agents useful in their preparation - Google Patents

Novel radiopharmaceuticals and chelating agents useful in their preparation

Info

Publication number
AU4632085A
AU4632085A AU46320/85A AU4632085A AU4632085A AU 4632085 A AU4632085 A AU 4632085A AU 46320/85 A AU46320/85 A AU 46320/85A AU 4632085 A AU4632085 A AU 4632085A AU 4632085 A AU4632085 A AU 4632085A
Authority
AU
Australia
Prior art keywords
preparation
chelating agents
agents useful
novel radiopharmaceuticals
radiopharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46320/85A
Other languages
English (en)
Inventor
Nicholas S. Bodor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Publication of AU4632085A publication Critical patent/AU4632085A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Conversion Of X-Rays Into Visible Images (AREA)
  • Luminescent Compositions (AREA)
  • Glass Compositions (AREA)
AU46320/85A 1984-07-19 1985-07-15 Novel radiopharmaceuticals and chelating agents useful in their preparation Abandoned AU4632085A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63238384A 1984-07-19 1984-07-19
US632383 1990-12-21

Publications (1)

Publication Number Publication Date
AU4632085A true AU4632085A (en) 1986-02-25

Family

ID=24535323

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46320/85A Abandoned AU4632085A (en) 1984-07-19 1985-07-15 Novel radiopharmaceuticals and chelating agents useful in their preparation

Country Status (14)

Country Link
EP (1) EP0191788A1 (fr)
JP (1) JPS61112054A (fr)
KR (1) KR900008168B1 (fr)
AU (1) AU4632085A (fr)
CA (1) CA1266864A (fr)
DK (1) DK124686A (fr)
ES (2) ES8700236A1 (fr)
FI (1) FI861119A0 (fr)
GR (1) GR851793B (fr)
IL (1) IL75845A0 (fr)
NO (1) NO860980L (fr)
PT (1) PT80842B (fr)
WO (1) WO1986000897A1 (fr)
ZA (1) ZA855477B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071636A (en) * 1987-12-29 1991-12-10 Nihon Medi-Physics Co., Ltd. Chelating compounds and their use
SE526214C2 (sv) * 2003-02-28 2005-07-26 Amersham Biosciences Ab Ett sätt att generera metallkelaterande affinitetsligander
KR101033209B1 (ko) * 2004-12-31 2011-05-06 주식회사 효성 분사성을 향상시킨 폴리에스테르 분섬사의 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
EP0110955B1 (fr) * 1982-05-18 1995-08-23 University Of Florida Administration d'un medicament a action specifique sur le cerveau

Also Published As

Publication number Publication date
CA1266864A (fr) 1990-03-20
ES8700236A1 (es) 1986-10-01
KR870000935A (ko) 1987-03-10
KR900008168B1 (en) 1990-11-05
WO1986000897A1 (fr) 1986-02-13
GR851793B (fr) 1985-11-26
EP0191788A1 (fr) 1986-08-27
FI861119A (fi) 1986-03-18
JPS61112054A (ja) 1986-05-30
IL75845A0 (en) 1985-11-29
FI861119A0 (fi) 1986-03-18
DK124686A (da) 1986-05-20
PT80842A (en) 1985-08-01
ZA855477B (en) 1987-03-25
DK124686D0 (da) 1986-03-18
NO860980L (no) 1986-05-06
ES552090A0 (es) 1987-05-01
ES8705389A1 (es) 1987-05-01
PT80842B (en) 1987-05-27
ES545395A0 (es) 1986-10-01

Similar Documents

Publication Publication Date Title
AU4177785A (en) Polyaminodithiols and radiopharmaceuticals
GB2159516B (en) Azaphthalocyanines and their use as photoactivators
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
GB2153883B (en) Improvements in cutter-bit assemblies
EP0157547A3 (en) Improvements in shuttlecocks
AU2755788A (en) Chelating compounds and their use
CY1522A (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols preparation and uses
IL71658A (en) 17-sulfonylmethylene-steroids and their preparation
ZA851830B (en) Controlled-release composition and the preparation thereof
ZA842202B (en) Phenylaminobenzenealkanols and preparation
AR244665A1 (es) Procedimiento para preparar 3-carbonil-1-amino-alquil-1h-indoles de utilidad como analgesicos.
ZA85973B (en) Hardenable composition and its use
IL73876A0 (en) Acylamino-mitosanes and their preparation
GB2139627B (en) 1 25-dihydroxylated vitamin d2 compounds and intermediates in the preparation thereof
EP0230052A3 (en) Immunoamplifiers and related compositions
NZ213581A (en) Carboxyalkyldipeptides and pharmaceutical compositions
DE3563624D1 (en) Novel substituted trifluorooxetane and preparation thereof
AU4632085A (en) Novel radiopharmaceuticals and chelating agents useful in their preparation
GB2164249B (en) Improvements in furniture
DE3571811D1 (en) Azetidine derivatives and their preparation
PH23727A (en) Imidazolylethoxyindanes and use as antithrombotic agents
IL87030A0 (en) Bicyclo-octanes and nonanes and compositions
DE3472250D1 (en) Novel halonitriles and their preparation
GB2141121B (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols and preparation